How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding

Ultrasound in Obstetrics and Gynecology

Volumn 24, Issue 5, 2004, Pages 558-565

  Smith Bindman, R ^a,b   Weiss, E ^a   Feldstein, V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Endometrial cancer; Incidental findings; Screening; Transvaginal; Transvaginal ultrasound

Indexed keywords

AGE; ARTICLE; CANCER RISK; CORRELATION ANALYSIS; ENDOMETRIAL THICKNESS; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; HIGH RISK POPULATION; HUMAN; META ANALYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; THICKNESS; TRANSVAGINAL ECHOGRAPHY; VAGINA BLEEDING; VALIDATION PROCESS;

AGED; BIOPSY; COHORT STUDIES; DECISION SUPPORT TECHNIQUES; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; REFERRAL AND CONSULTATION; RISK FACTORS;

EID: 6344253943     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1002/uog.1704     Document Type: Article

References (21)

1. Hawwa ZM, Nahhas WA, Copenhaver EH. Postmenopausal bleeding. Labey Clin Found Bull 1970; 19: 61-70.
2. Rose PG. Endometrial carcinoma. N Engl J Med 1996; 335: 640-649.
3. Disaia P, Creasman W. Clinical Gynecologic Oncology (6th edn). Mosby-Year Book: St Louis, MO: 2002.
4. American College of Obstetricians and Gynecologists (ACOG). Gynecologic Ultrasonography, 2000 Compendium of Selected Publications. ACOG: Washington, DC, 2000.
5. Goldstein RB, Bree RL, Benson CB, Benacerraf BR, Bloss JD, Carlos R, Fleischer AC, Goldstein SR, Hunt RB, Kurman RJ, Kurtz AB, Laing FC, Parsons AK, Smith-Bindman R, Walker J. Evaluation of the woman with postmenopausal bleeding: Society of Radiologists in Ultrasound-Sponsored Consensus Conference statement. J Ultrasound Med 2001; 20: 1025-1036.
6. Tabor A, Watt H, Wald N. Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding. Obstet Gynecol 2002; 99: 663-670.
7. Smith-Bindman R, Kerlikowske K, Feldstein VA, Subak L, Scheidler J, Segal M, Brand R, Grady D. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 1998; 280: 1510-1517.
8. Feldman S, Berkowitz R, Tosteson A. Cost-effectiveness of strategies to evaluate postmenopausal bleeding. Obstet Gynecol 1993; 81: 968-975.
9. Archer DF, McIntyre SK, Wilborn WJ, Dowling EA, Cone F, Creasy GW, Kafrissen ME. Endometrial morphology in asymptomatic postmenopausal women. Am J Obstet Gynecol 1991; 165: 317-320.
10. Fleischer AC, Wheeler JE, Lindsay I, Hendrix SL, Grabill S, Kravitz B, MacDonald B. An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms. Am J Obstet Gynecol 2001; 184: 70-75.
11. Langer RD, Pierce JJ, O'Hanlan KA, Johnson SR, Espeland MA, Trabal JF, Barnabei VM, Merino MJ, Scully RE. Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. Postmenopausal Estrogen/Progestin Interventions Trial. N Engl J Med 1997; 337: 1792-1798.
12. Love CD, Muir BB, Scrimgeour JB, Leonard RC, Dillon P, Dixon JM. Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. J Clin Oncol 1999; 17: 2050-2054.
13. Warming L, Ravn P, Skouby S, Christiansen C. Measurement precision and normal range of endometrial thickness in a postmenopausal population by transvaginal ultrasound. Ultrasound Obstet Gynecol 2002; 20: 492-495.
14. The Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333.
15. The Writing Group for the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1996; 275: 370-375.
16. Hofmeister F. Endometrial biopsy: another look. Am J Obstet Gynecol 1974; 118: 773-776.
17. SEER, Surveillance, Epidemiology, and End Results Program. National Institutes of Health, National Cancer Institute: Bethesda, MD, 2000.
18. Bourne TH, Campbell S, Whitehead MI, Royston P, Steer CV, Collins WP. Detection of endometrial cancer in postmenopausal women by transvaginal ultrasonography and colour flow imaging. BMJ 1990; 301: 369.
19. Fleischer AC, Wheeler JE, Yeh IT, Kravitz B, Jensen C, MacDonald B. Sonographic assessment of the endometrium in osteopenic postmenopausal women treated with idoxifene. J Ultrasound Med 1999; 18: 503-512.
20. Saraiya M, Lee NC, Blackman D, Smith MJ, Morrow B, McKenna MA. Self-reported Papanicolaou smears and hysterectomies among women in the United States. Obstet Gynecol 2001; 98: 269-278.
21. Osmers R, Volksen M, Rath W, Teichmann A, Kuhn W. Vaginosonographic measurement of the postmenopausal endometrium in the early detection of endometrial cancer. Geburtshilfe Frauenheilkd 1989; 49: 262-265.